Little is known about the causes of brain tumors in children. Children with one of several genetic disorders including tuberous sclerosis and Li-Fraumeni syndrome are at increased risk, as are children who have received therapeutic irradiation to their head. The multifactorial causation of brain tumors, the inaccuracies of recall of past exposures, and the study of all pediatric brain tumors as a single etiologic entity may be contributing to the difficulty in identifying additional risk factors. The evidence that frequent cured meat consumption by the mother during pregnancy increases the risk is suggestive but not conclusive. For other potential risk factors, the evidence is limited and/or conflicting. These exposures and characteristics include pesticides, carcinogen metabolizing genes, and polyomaviruses.

Keywords:
Brain tumors, Epidemiology, Risk factors, Childhood cancer, Cured meat
1.
Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK (eds): SEER Cancer Statistics Review, 1973–1994. Bethesda, National Cancer Institute, NIH Publication No 97–2789, 1997.
2.
Bunin GR, Feuer EJ, Witman PA, Meadows AT: Increasing incidence of childhood cancer: Report of 20 years experience from the Greater Delaware Valley Pediatric Tumor Registry. Paediatr Perinat Epidemiol 1996;10:319–338.
3.
Smith MA, Freidlin B, Gloeckler Ries LA, Simon R: Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 1998;90:1269–1277.
4.
Young JL, Ries LG, Silverberg E, Horm JW, Miller RW: Cancer incidence, survival, and mortality for children younger than 15 years. Cancer 1986;58:598–602.
5.
Schoenberg BS, Schoenberg DG, Christine BW, Gomez MR: The epidemiology of primary intracranial neoplasms of childhood. A population study. Mayo Clin Proc 1976;51:51–56.
6.
Mealey J, Hall PV: Medulloblastoma in children: Survival and treatment. J Neurosurg 1977;46:56–64.
7.
Ron E, Modan B, Boice JD, Alfandary E, Stovall M, Chetrit A, Katz L: Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988;319:1033–1039.
8.
Werler MM, Pober BR, Nelson K, Holmes LB: Reporting accuracy among mothers of malformed and nonmalformed infants. Am J Epidemiol 1989;129:415–421.
9.
Lijinsky W: Chemistry and biology of N-nitroso compounds. New York, Cambridge University Press, 1992.
10.
National Academy of Sciences: The Health Effects of Nitrate, Nitrite and N-Nitroso Compounds. Washington, National Academy Press, 1981.
11.
Preston-Martin S, Yu MC, Benton B, Henderson BE: N-Nitroso compounds and childhood brain tumors: A case-control study. Cancer Res 1982;42:5240–5245.
12.
Kuijten RR, Bunin GR, Nass CC, Meadows AT: Gestational and familial risk factors for childhood astrocytoma: Results of a case-control study. Cancer Res 1990;50:2608–2612.
13.
Bunin GR, Kuijten RR, Buckley JD, Rorke LB, Meadows AT: Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 1993;329:536–541.
14.
Bunin GR, Kuijten RR, Boesel CP, Buckley JD, Meadows AT: Maternal diet and risk of astrocytic glioma in children: A report from the Children’s Cancer Group. Cancer Causes Control 1994;5:177–187.
15.
McCredie M, Maisonneuve P, Boyle P: Antenatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer 1994;56:6–10.
16.
Sarasua S, Savitz DA: Cured and broiled meat consumption in relation to childhood cancer. Denver, Colorado (United States). Cancer Causes Control 1994;5:141–148.
17.
Cordier S, Iglesias MJ, Goaster CL, Guyot MM, Mandereau L, Hemon D: Incidence and risk factors for childhood brain tumors in the Ile de France. Int J Cancer 1994;59:776–782.
18.
Schymura MJ, Zheng D, Baptiste MS, Nasca PC: A case-control study of childhood brain tumors and maternal lifestyle. Am J Epidemiol 1996;143:S8.
19.
Preston-Martin S, Pogoda JM, Mueller BA, Holly EA, Lijinsky W, Davis RL: Maternal consumption of cured meats and vitamins in relation to pediatric brain tumors. Cancer Epidemiol Biomarkers Prev 1996;5:599–605.
20.
Miller RW: Deaths from childhood leukemia and solid tumors among twins and other sibs in the United States, 1960–1967. J Natl Cancer Inst 1971;46:203–209.
21.
Draper GJ, Heaf MM, Kinnier Wilson LM: Occurrence of childhood cancers among sibs and estimation of familial risks. J Med Genet 1977;14:81–90.
22.
Farwell J, Flannery JT: Cancer in relatives of children with nervous-system neoplasms. N Engl J Med 1984;311:749–753.
23.
Gold EB, Leviton A, Lopez R, Austin DF, Gilles FH, Hedley-Whyte ET, Kolonel LN, Lyon JL, Swanson GM, Weiss NS, West DW, Aschenbrener C: The role of family history in risk of childhood brain tumors. Cancer 1994;73:1302–1311.
24.
Giuffre R, Liccardo G, Pastore FS, Spallone A, Vagnozzi R: Potential risk factors for brain tumors in children: An analysis of 200 cases. Childs Nerv Syst 1990;6:8–12.
25.
Kuijten RR, Strom SS, Rorke LB, Boesel CP, Buckley JD, Meadows AT, Bunin GR: Family history of cancer and seizures in young children with brain tumors: A report from the Children’s Cancer Group (United States and Canada). Cancer Causes Control 1993;4:455–464.
26.
Seidegard J, Vorachek WR, Pero RW, Pearson WR: Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988;85:7293–7297.
27.
Rebbeck TR: Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733–743.
28.
Elexpuru-Camiruaga J, Buxton N, Kandula V, Dias PS, Campbell D, McIntosh J, Broome J, Jones P, Inskip A, Alldersea J, Fryer AA, Strange RC: Susceptibility to astrocytoma and meningioma: Influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res 1995;55:4237–4239.
29.
Wiencke JK, Pemble S, Ketterer B, Kelsey KT: Gene deletion of glutathione S-transferase 0: Correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 1995;4:253–259.
30.
Trizna Z, de Andrade M, Kyritsis AP, Briggs K, Levin VA, Bruner JM, Wei Q, Bondy ML: Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiol Biomarkers Prev 1998;7:553–555.
31.
Kelsey KT, Wrensch M, Zuo ZF, Miike R, Wiencke JK: A population-based case-control study of the CYP2D6 and GSTT1 polymorphisms and malignant brain tumors. Pharmacogenetics 1997;7:463–468.
32.
Barbanti-Brodano G, Martini F, De Mattei M, Lazzarin L, Corallini A, Tognon M: BK and JC human polyomaviruses and Simian virus 40: Natural history of infection in humans, experimental oncogenicity, and association with human tumors. Adv Virus Res 1998;50:69–99.
33.
Taguchi F, Kajioka J, Miyamura T: Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol 1982;26:1057–1064.
34.
Butel JS, Lednicky JA: Cell and molecular biology of simian virus 40: Implications for human infections and disease. J Natl Cancer Inst 1999;91:119–134.
35.
Jafar S, Rodriguez-Barradas M, Graham DY, Butel JS: Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol 1998;54:276–284.
36.
Major EO, Neel JV: The JC and BK human polyoma viruses appear to be recent introductions to some South American Indian tribes: There is no serological evidence of cross-reactivity with the simian polyoma virus SV40. Proc Natl Acad Sci USA 1998;95:15525–15530.
37.
Strickler H, Goedert J, Fleming M, Travis W, Williams A, Rabkin C, Daniel R, Shah K: Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev 1996;5:473–475.
38.
Krynska B, Del Valle L, Croul S, Gordon J, Katsetos CD, Carbone M, Giordano A, Khalili K: Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci USA 1999;96:11519–11524.
39.
Huang H, Reis R, Yonekawa Y, Lopes JM, Kleihues P, Ohgaki H: Identification in human brain tumors of DNA sequences specific for SV40 large T antigen (see comments). Brain Pathol 1999;9:33–42.
40.
Martini F, Iaccheri L, Lazzarin L, Carinci P, Corallini A, Gerosa M, Iuzzolino P, Barbanti- Brodano G, Tognon M: SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 1996;56:4820–4825.
41.
De Mattei M, Martini F, Corallini A, Gerosa M, Scotlandi K, Carinci P, Barbanti-Brodano G, Tognon M: High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes. Int J Cancer 1995;61:756–760.
42.
Davis JR, Brownson RC, Garcia R, Bentz BJ, Turner A: Family pesticide use and childhood brain cancer. Arch Environ Contam Toxicol 1993;24:87–92.
43.
Leiss JK, Savitz DA: Home pesticide use and childhood cancer: A case-control study. Am J Public Health 1995;85:249–252.
44.
Pogoda JM, Preston-Martin S: Household pesticides and risk of pediatric brain tumors. Environ Health Perspect 1997;105:1214–1220.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.